Jane Street Group, LLC Denali Therapeutics Inc. Transaction History

Jane Street Group, LLC

$88.2 Billion
Q2 2024

A detailed history of Jane Street Group, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 231,364 shares of DNLI stock, worth $7.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

231,364

Previous 48,716 374.92%

Holding current value

$7.12 Million

Previous $999,000 437.74%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$14.96 - $23.22 $2.73 Million - $4.24 Million	182,648 Added 374.92%	231,364 $5.37 Million
Q1 2024 May 15, 2024	SELL	$15.83 - $23.35 $1.59 Million - $2.34 Million	-100,249 Reduced 67.3%	48,716 $999,000
Q4 2023 Feb 14, 2024	BUY	$16.2 - $23.18 $1.79 Million - $2.56 Million	110,226 Added 284.53%	148,965 $3.2 Million
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $702,678 - $1.03 Million	-34,061 Reduced 46.79%	38,739 $799,000
Q2 2023 Aug 14, 2023	SELL	$23.37 - $32.96 $1.01 Million - $1.42 Million	-43,005 Reduced 37.14%	72,800 $2.15 Million
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $2.21 Million - $3.29 Million	100,836 Added 673.63%	115,805 $2.67 Million
Q4 2022 Feb 14, 2023	BUY	$26.28 - $33.92 $393,385 - $507,748	14,969 New	14,969 $416,000
Q2 2022 Aug 16, 2022	BUY	$20.88 - $35.19 $290,712 - $489,950	13,923 New	13,923 $410,000
Q1 2022 May 17, 2022	SELL	$29.0 - $47.27 $709,224 - $1.16 Million	-24,456 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$42.59 - $55.02 $245,275 - $316,860	5,759 Added 30.8%	24,456 $1.09 Million
Q3 2021 Nov 16, 2021	BUY	$48.48 - $78.23 $697,336 - $1.13 Million	14,384 Added 333.5%	18,697 $943,000
Q2 2021 Aug 16, 2021	SELL	$50.3 - $78.44 $436,000 - $679,917	-8,668 Reduced 66.77%	4,313 $338,000
Q1 2021 May 18, 2021	SELL	$53.8 - $81.53 $1.06 Million - $1.6 Million	-19,613 Reduced 60.17%	12,981 $741,000
Q4 2020 Feb 17, 2021	BUY	$36.89 - $93.56 $101,373 - $257,102	2,748 Added 9.21%	32,594 $2.73 Million
Q3 2020 Nov 17, 2020	BUY	$23.13 - $38.84 $160,036 - $268,733	6,919 Added 30.18%	29,846 $1.07 Million
Q2 2020 Aug 17, 2020	SELL	$16.01 - $28.82 $256,784 - $462,243	-16,039 Reduced 41.16%	22,927 $554,000
Q1 2020 May 15, 2020	BUY	$14.2 - $27.98 $553,317 - $1.09 Million	38,966 New	38,966 $683,000
Q4 2019 Feb 14, 2020	SELL	$14.4 - $19.99 $186,854 - $259,390	-12,976 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$15.32 - $21.92 $198,792 - $284,433	12,976 New	12,976 $199,000
Q4 2018 Feb 15, 2019	SELL	$13.88 - $21.75 $139,077 - $217,935	-10,020 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.46 - $21.74 $124,849 - $217,834	10,020 New	10,020 $218,000

Others Institutions Holding DNLI

# of Institutions

214

Shares Held

121M

Call Options Held

127K

Put Options Held

38.3K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $4.13B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Denali Therapeutics Inc. Transaction History